These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Does Catapresan reduce the intraocular pressure independently from blood pressure?]. Leydhecker W; Hertlein E Klin Monbl Augenheilkd; 1971 Nov; 159(5):574-7. PubMed ID: 5136276 [No Abstract] [Full Text] [Related]
3. [Treatment of glaucoma with catapresan]. Honegeer H; Wachholz E Klin Monbl Augenheilkd; 1971 Feb; 158(2):306-7. PubMed ID: 5555611 [No Abstract] [Full Text] [Related]
4. [Drug influences on the visual organs and traffic]. Gramberg-Danielsen B Ophthalmologica; 1969; 158 Suppl():410-6. PubMed ID: 5359742 [No Abstract] [Full Text] [Related]
5. [The influence of 2-(1,2,3,4-tetrahydroxy-1-naphthylamino)-2-imidazoline hydrochloride on intraocular pressure and conjunctival hyperemia of the human eye]. Aust W; Rüger K Arzneimittelforschung; 1970 Oct; 20(10):1557-8. PubMed ID: 5536424 [No Abstract] [Full Text] [Related]
7. Ocular hypotensive medications for the treatment of glaucoma. Lee DA Ophthalmol Clin North Am; 2005 Dec; 18(4):529-38. PubMed ID: 16314217 [TBL] [Abstract][Full Text] [Related]
8. [Mode and principle of action of Catapresan in glaucoma therapy]. Jünemann G; Paust E Klin Monbl Augenheilkd; 1971 Apr; 158(4):501-13. PubMed ID: 5578931 [No Abstract] [Full Text] [Related]
9. [Clinical studies on the mechanism of action of 2-(2,6-dichlorphenylamino)-2-imidazolinehydrochloric acid (Catapresan)]. Scheja HW; Strum A Verh Dtsch Ges Inn Med; 1968; 74():559-62. PubMed ID: 5714381 [No Abstract] [Full Text] [Related]
10. [Ophthalmological studies with dichlorophenylaminoimidazoline with special regard to its effect on intraocular pressure]. Makabe R Dtsch Med Wochenschr; 1966 Sep; 91(38):1686-8. PubMed ID: 5917871 [No Abstract] [Full Text] [Related]
11. New drug information. Combigan. JAAPA; 2008 Feb; 21(2):14. PubMed ID: 18326089 [No Abstract] [Full Text] [Related]
12. [Examinations of the effect of catapresan on intraocular pressure]. Heilmann K Klin Monbl Augenheilkd; 1970 Aug; 157(2):182-92. PubMed ID: 5505705 [No Abstract] [Full Text] [Related]
13. [Effect of catapresan on the glaucomatous eye]. Jünemann G; Schmidt G Klin Monbl Augenheilkd; 1970 Aug; 157(2):193-201. PubMed ID: 5505706 [No Abstract] [Full Text] [Related]
14. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension]. Borrello G Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286 [No Abstract] [Full Text] [Related]
15. The pharmacology of dl-1-(4-hydroxyphenyl)-2-isopropylamino ethanol hydrochloride, an ocular hypotensive agent in rabbits. Leaders FE; Fortenberry BR; Chiang TS; Van Hoose MC Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):368-82. PubMed ID: 5575590 [No Abstract] [Full Text] [Related]
16. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses. Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830 [TBL] [Abstract][Full Text] [Related]
17. [Approaches to reduction of intraocular pressure by 30% in patients with glaucoma (review of literature)]. Kuroedov AV; Brezhnev AIu; Aleksandrov AS Voen Med Zh; 2009 Jun; 330(6):40-6. PubMed ID: 19791687 [No Abstract] [Full Text] [Related]
19. [Studies on the effect of Catapresan on the intraocular pressure]. Heilmann K Klin Monbl Augenheilkd; 1971 Apr; 158(4):493-500. PubMed ID: 5578930 [No Abstract] [Full Text] [Related]